Miralles Gines Diego 4
4 · Contineum Therapeutics, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Miralles Gines Diego
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-14+29,500→ 29,500 totalExercise: $6.67Exp: 2035-03-13→ Class A Common Stock (29,500 underlying)
Footnotes (1)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended. One-third of the option shares vest on March 14, 2026, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.